美國的顱內壓 (ICP) 監測市場
US Market Report for Intracranial Pressure Monitoring 2017 - MedCore
|出版商||iData Research Inc.||商品編碼||370984|
|出版日期||內容資訊||英文 78 Pages
|美國的顱內壓 (ICP) 監測市場 US Market Report for Intracranial Pressure Monitoring 2017 - MedCore|
|出版日期: 2016年09月01日||內容資訊: 英文 78 Pages||
本報告提供美國的顱內壓 (ICP) 監測市場相關調查分析，提供您市場概要，市場分析與預測，推動因素·阻礙因素，競爭分析等系統性資訊。
The total market for ICP monitoring includes ICP transducers, drainage kits, advanced monitoring technologies and disposables as well as universal disposables that can be used by both basic and advanced technologies. Advanced ICP monitoring is driven by sales of disposables, namely access kits and ventricular catheters, as well as transducers. ICP sensors and transducers require the use of a monitor that is separate from a patient's multi-parameter bedside monitor; however, there is generally provision to integrate the two systems in order to enable surveillance through a single, often networked, monitoring platform. Some advanced monitors also carry the option of monitoring cerebral tissue oxygen saturation and can be synced with the both the ICP and multi-parameter monitors to ensure that all relevant measurements are readily available. While sales of ICP monitors with tissue oxygen saturation have added value to the advanced monitoring market it still represents a minority of the ICP advanced monitoring segment revenue. Over the forecast period this revenue mix is expected to shift in favor of the disposables as demand for ICP monitoring and CSF management increases and basic external monitoring procedures continue to dominate.
The cerebrospinal fluid (CSF) acts as a cushion between the brain and the skull. In healthy individuals, it is circulated though the brain and its ventricles, the spine and the circulatory system. However, there are cases where the amount of CSF surrounding the brain changes significantly. As a result, intracranial pressure (ICP) can increase to damaging levels. If left untreated, significant levels of discomfort and pain as well as the onset of more severe complications such as loss of consciousness, blindness and brain damage can result. It is important to note that ICP levels can also become abnormally low; however, these cases are extremely rare. In the event of low ICP levels, similar symptoms are shown.
Other applications of ICP monitoring include the diagnosis of conditions such as benign intracranial hypertension, management of neurological cases, and guidance of follow-up therapy. Complications resulting from unchecked increases or decreases in ICP can include convulsions or even death.